跳至內容

FV-100

維基百科,自由的百科全書
FV-100
IUPAC名
3-(2-Deoxy-β-D-erythro-pentofuranosyl)-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-2(3H)-one
系統名
3-[(2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-2(3H)-one
別名 Cf1743
識別
CAS號 956483-02-6  checkY
PubChem 493485
ChemSpider 431897
SMILES
 
  • CCCCCC1=CC=C(C=C1)C2=CC3=CN(C(=O)N=C3O2)[C@H]4C[C@@H]([C@H](O4)CO)O
性質
化學式 C22H26N2O5
摩爾質量 398.45 g·mol−1
若非註明,所有數據均出自標準狀態(25 ℃,100 kPa)下。

FV-100(也稱為Cf1743)是一種含氮有機化合物,分子式C
22
H
26
N
2
O
5
,屬於核苷酸類似物[1],可作為抗病毒藥物[2],用於治療帶狀疱疹[3]

參考文獻

[編輯]
  1. ^ Inhibitex Completes Phase I Clinical Trials For FV-100 And Selects Lead HCV Compounds For Advanced Preclinical Studies, 2009 
  2. ^ McGuigan, Christopher; Balzarini, Jan. FV100 as a new approach for the possible treatment of varicella-zoster virus infection. Journal of Antimicrobial Chemotherapy. 2009, 64 (4): 671–673. PMID 19679595. doi:10.1093/jac/dkp294可免費查閱. 
  3. ^ Tyring, SK; Lee, P; Hill GT, Jr; Silverfield, JC; Moore, AY; Matkovits, T; Sullivan-Bolyai, J. FV-100 versus valacyclovir for the prevention of post-herpetic neuralgia and the treatment of acute herpes zoster-associated pain: A randomized-controlled trial.. Journal of medical virology. 2017-07, 89 (7): 1255–1264. PMID 27943311. doi:10.1002/jmv.24750. 

外部連結

[編輯]